GlaxoSmithKline Cutting Prices to Gain Market Share in China
ChinaBio Today submits: Because GlaxoSmithKline (GSK) wants to double its China and India revenues by 2015, the company will significantly reduce its prices – as much as 70% – to raise revenues. The company readily admits it is trailing its multinational rivals such as Pfizer (PFE) and Sanofi-Aventis (SNY) in developing markets.Abbas Hussain, President of Emerging Markets for Glaxo, said in an interview with Bloomberg News:Complete Story » seekingalpha.com |
Rory Delap supports Back in Play - Video
Throw-In Legend Rory Delap Urges Fans not to Dismiss Lower Back Pain feedproxy.google.com |
Matrixx Initiatives, Inc. F1Q11 (Qtr End 06/30/10) Earnings Call Transcript
Matrixx Initiatives, Inc. (MTXX)F1Q11 (Qtr End 06/30/10) Earnings Call TranscriptAugust 4, 2010 11:00 am ETComplete Story » seekingalpha.com |
Shell / Cosan's Big Bet on Biofuels
The Burrill Report submits: By Marie DaghlianA $12-billion joint venture between Shell (RDS.A) and Brazilian ethanol producer Cosan (CZZ) moved closer to reality as the two companies signed binding agreements on the a deal first proposed in February. If completed, the deal will create the third largest ethanol producer in the world with 4,500 retail stations and annual production of 440 million gallons. Complete Story » seekingalpha.com |
CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at 'The Marijuana Conference' in New York City on Oct. 25 & 26
[PR Newswire] - Cannabis Science, Inc. , a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce the upcoming coverage by CNBC, Discovery Channel and National Geographic for the speaking engagement of Dr. us.rd.yahoo.com |